Holbrook Kerr 4
4 · AVANOS MEDICAL, INC. · Filed Mar 19, 2024
Insider Transaction Report
Form 4
Holbrook Kerr
SVP, Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2024-03-18+2,531→ 89,727 total - Tax Payment
Common Stock
2024-03-18$19.09/sh−756$14,432→ 88,971 total - Tax Payment
Common Stock
2024-03-18$19.09/sh−2,840$54,216→ 86,131 total
Footnotes (3)
- [F1]Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each PRSU is the economic eqiuvalent of one share of Common Stock.
- [F2]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 2,531 PRSUs which vested on March 18, 2024.
- [F3]Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 9,516 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 17, 2021 and (ii) vested on March 18, 2024. Each TRSU is the economic equivalent of one share of Common Stock.